Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fraunhofer IZI coordinates EU project of neurodegenerative diseases such as Alzheimer's & Parkinson

22.06.2015

7 June 2015 marked the start of a joint European project in Halle intended to shed light on common molecular features in the early development of neurodegenerative diseases. Five partner institutions from Halle, Leipzig, Erlangen, Paris (France) and Oslo (Norway) have set themselves the goal of working on therapeutic strategies based on new findings. The project, which is set to run over a three-year period, has been awarded a total of 1.7 million euros in funding from the European Union.

Besides the devastating effects they have on patients, neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's diseases have one key thing in common: their pathology is based on the aggregation and accumulation of misfolded proteins in the brain.

This results in a loss of tissue and function and, consequently, severe neurological disorders which are fatal in the advanced stages of the diseases. Until now, the mechanisms associated with the early development of these diseases have mainly been researched independently of each other.

Latest investigations, however, have suggested similarities in the molecular development processes of the diseases. This is centered around the hypothesis that misfolded peptides, which frequently arise in the case of such diseases, also induce a deposit of other proteins.

This means that a peptide triggers degenerative processes which become more intense through the coaggregation of peptides. The main target proteins to be investigated include Abeta, alpha-synuclein and huntingtin.

Fraunhofer IZI's Molecular Drug Biochemistry and Therapy Development (MWT) project group is coordinating the EU project and aims to research these common features and develop new therapeutic strategies.

Led by Professor Hans-Ulrich Demuth and Dr Stephan Schilling, the group will contribute their many years of experience researching misfolded proteins to the project. Consequently, the Halle scientists have set themselves the chief task of synthesizing respective proteins and antibodies for their subsequent investigation. At Leipzig University, detailed investigations into the development of Alzheimer's will then be carried out building on this research.

At the Friedrich-Alexander University Erlangen-Nürnberg, the focus is placed on research into Huntington's disease, while the French National Institute of Health and Medical Research in Paris will look at the development of Parkinson's disease with an eye to the aspects mentioned above. At the University of Oslo, a computer-based database will be created, which will draw on the histological data generated by the units in order to gain a corresponding, local correlation between protein deposits in the brain for each different disease model.

Information on funding
This project is being funded by the "EU Joint Programme – Neurodegenerative Disease Research (JPND)", the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases. JPND aims to increase the coordinated investments of its partner countries and thus to support research which looks to identify causes of disease, therapy development and suitable care measures for patients. Further information can be found at: www.jpnd.eu

Weitere Informationen:

http://www.izi.fraunhofer.de/fraunhofer-izi.html?&L=1

Presse Institute | Fraunhofer-Gesellschaft

More articles from Health and Medicine:

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

nachricht Flexible sensors can detect movement in GI tract
11.10.2017 | Massachusetts Institute of Technology

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Ocean atmosphere rife with microbes

17.10.2017 | Life Sciences

Neutrons observe vitamin B6-dependent enzyme activity useful for drug development

17.10.2017 | Life Sciences

NASA finds newly formed tropical storm lan over open waters

17.10.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>